Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt

Sleep Disorders: later-stage trial registry

All 20 indexed Sleep Disorders trials have closed enrollment; the archived set skews later-stage.

Corpus placement: #848 of 28,707 conditions by registered trial count.

20 US clinical trials · none currently recruiting · #848 of 28,707 conditions by registered trial count

Sleep Disorders: 20 US clinical trials tracked, none currently recruiting.

Sleep Disorders is the subject of 20 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 4 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Mental Health (NIMH), running 2 of these trials.

Enrollment posture brief

Registry condition sleep-disorders

OPEN 0 | RECR 0% | LATE 4 | EARLY 1 | RANK #848 | SPON 2

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Advanced or Metastatic Solid55%ALS50%Abdominal Pain25%Acute Myocardial Infarction25%Sleep Disorders (this)0%
Open-enrollment share among volume-matched conditions near Sleep Disorders

Sleep Disorders has no open enrollment in this registry pull (20 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Sleep Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Sleep Disorders is recruiting below its size-band peers.

    0 of 20 indexed trials (0%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Sleep Disorders trials is spread across many organizations.

    National Institute of Mental Health (NIMH) accounts for 2 of 20 trials (10%). 18 distinct sponsors appear on at least one study for this condition label.

  3. Typical Sleep Disorders enrolment sits around 90 participants.

    Median target enrolment is 90 among the 20 trials that report a genuine target (sentinel values excluded). 11 of those (55%) plan for fewer than 100 participants.

  4. Sleep Disorders research is mostly interventional.

    15 interventional and 5 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 33Phase 41

Indexed trials (enrollment closed)

20 total, page 1 of 1

ACTIVE NOT RECRUITING 1,545 participants

Epidemiology of Sleep-Disordered Breathing in Adults

University of Wisconsin, Madison

NCT00005557

ACTIVE NOT RECRUITING NA 889 participants

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

Canadian Cancer Trials Group

NCT00819208

ACTIVE NOT RECRUITING 100 participants

Sleep Actigraphy in Postural Tachycardia Syndrome (POTS)

Satish R. Raj

NCT00692471

ACTIVE NOT RECRUITING NA 90 participants

Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms

Jonsson Comprehensive Cancer Center

NCT00690196

COMPLETED 1,944 participants

Family Study of Affective and Anxiety Spectrum Disorders

National Institute of Mental Health (NIMH)

NCT00071786

COMPLETED Phase 2 410 participants

Yoga in Treating Sleep Disturbance in Cancer Survivors

Gary Morrow

NCT00397930

COMPLETED 325 participants

Pediatric Sleep Questionnaire: Normalization and Validation Study

University of Chicago

NCT00203840

COMPLETED Phase 3 304 participants

Cooperative Studies Program #563 - Prazosin and Combat Trauma PTSD

VA Office of Research and Development

NCT00532493

COMPLETED Phase 3 227 participants

(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy

Alliance for Clinical Trials in Oncology

NCT00075842

COMPLETED Phase 3 119 participants

Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia

Pfizer's Upjohn has merged with Mylan to form Viatris

NCT00883740

COMPLETED NA 90 participants

"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"

University of Wisconsin, Madison

NCT01317329

COMPLETED 38 participants

Circadian Regulation of Sleep in Habitual Short Sleepers and Long Sleepers

National Institute of Mental Health (NIMH)

NCT00001546

COMPLETED NA 33 participants

Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors

Ohio State University Comprehensive Cancer Center

NCT01929720

COMPLETED NA 29 participants

Phase II Early Behavioral Intervention in BMT w/ Sleep Disturbance-Assess QOL+Fatigue+Cognitive f(x)

Stanford University

NCT01536977

COMPLETED NA 26 participants

Use of an Educational Story to Prepare Children With Developmental Disabilities for Sleep Study

Jennifer Accardo

NCT02132273

COMPLETED NA 21 participants

Efficacy of a Brief Nightmare Treatment for Veterans

University of Tul

NCT01220401

COMPLETED NA 20 participants

Zolpidem CR and Hospitalized Patients With Dementia

Massachusetts General Hospital

NCT00814502

COMPLETED Phase 4 19 participants

The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia

Mansoor Ahmed M.D.

NCT01234675

COMPLETED NA 16 participants

Sleep Length and Circadian Regulation in Humans

Rush University Medical Center

NCT00843843

COMPLETED NA 10 participants

Whole Body Periodic Acceleration on Activity and Sleep In Parkinson's Disease

New York Institute of Technology

NCT02874261

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 3
Phase 4 1

Named interventions

Most-linked intervention names on Sleep Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
3 trials
questionnaire administration Other
2 trials
placebo Other
2 trials
exposure, relaxation, and rescription therapy Behavioral
1 trials
Cognitive-behavioral therapy for worry, uncertainty & insomnia Behavioral
1 trials
Valeriana officinalis extract Dietary supplement
1 trials
educational intervention Behavioral
1 trials
cognitive assessment Behavioral
1 trials

US sites by state

Facility locations filed on Sleep Disorders trials. A trial with sites in several states counts in each.

Ohio 4 trials
North Carolina 4 trials
Illinois 4 trials
California 4 trials
Wisconsin 3 trials
New York 3 trials
Maryland 3 trials
Kansas 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Sleep Disorders page

20 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Sleep Disorders condition card totals 20 registered trials; most-linked intervention Placebo; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.